Sex differences in cancer incidence: prospective analyses in the UK Biobank.
Khan M. et al, (2025), Br J Cancer
Amount and intensity of daily total physical activity, step count and risk of incident cancer in the UK Biobank.
Shreves AH. et al, (2025), Br J Sports Med
Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study.
Almanza-Aguilera E. et al, (2024), Cancers (Basel), 16
Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses.
Wang SE. et al, (2024), EBioMedicine, 108
Cluster effect for SNP-SNP interaction pairs for predicting complex traits.
Lin H-Y. et al, (2024), Sci Rep, 14
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.
Desai TA. et al, (2024), EBioMedicine, 105
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.
Yarmolinsky J. et al, (2024), J Natl Cancer Inst, 116, 764 - 765
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers.
Smith-Byrne K. et al, (2024), Nat Commun, 15
Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
Rinaldi S. et al, (2024), Int J Cancer
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J. et al, (2024), EBioMedicine, 100
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study.
Watts EL. et al, (2024), Br J Cancer, 130, 114 - 124
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Wang A. et al, (2023), Nat Genet, 55, 2065 - 2074
Dose-response of accelerometer-measured physical activity, step count, and cancer risk in the UK Biobank: a prospective cohort analysis.
Shreves AH. et al, (2023), Lancet, 402 Suppl 1
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
Darst BF. et al, (2023), JAMA Oncol, 9, 1514 - 1524
Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a european cohort study.
Hughes DJ. et al, (2023), Free Radic Biol Med
Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries.
Tong TYN. et al, (2023), Eur J Nutr
Associations of intakes of total protein, protein from dairy sources, and dietary calcium with risks of colorectal, breast, and prostate cancer: a prospective analysis in UK Biobank.
Watling CZ. et al, (2023), Br J Cancer, 129, 636 - 647